These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

59 related articles for article (PubMed ID: 8093552)

  • 1. Electrophysiologically guided antiarrhythmic therapy versus beta-blocker therapy in patients with ventricular tachyarrhythmias.
    Vaitkus PT; Capeless MA
    N Engl J Med; 1993 Feb; 328(5):357; author reply 358. PubMed ID: 8093552
    [No Abstract]   [Full Text] [Related]  

  • 2. Electrophysiologically guided antiarrhythmic therapy versus beta-blocker therapy in patients with ventricular tachyarrhythmias.
    Stanton MS; Gersh BI; Hammill SC
    N Engl J Med; 1993 Feb; 328(5):357-8. PubMed ID: 8419829
    [No Abstract]   [Full Text] [Related]  

  • 3. A comparison of electrophysiologically guided antiarrhythmic drug therapy with beta-blocker therapy in patients with symptomatic, sustained ventricular tachyarrhythmias.
    Steinbeck G; Andresen D; Bach P; Haberl R; Oeff M; Hoffmann E; von Leitner ER
    N Engl J Med; 1992 Oct; 327(14):987-92. PubMed ID: 1355595
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A randomized study of the prevention of sudden death in patients with coronary artery disease. Multicenter Unsustained Tachycardia Trial Investigators.
    Buxton AE; Lee KL; Fisher JD; Josephson ME; Prystowsky EN; Hafley G
    N Engl J Med; 1999 Dec; 341(25):1882-90. PubMed ID: 10601507
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Combination of celiprolol and amiodarone in the treatment of recurrent ventricular tachycardia].
    Tonet J; Hidden F; Naditch L; Coutte R; Himbert C; Frank R
    Ann Cardiol Angeiol (Paris); 1996 Jan; 45(1):18-23. PubMed ID: 8815771
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Anti-arrhythmia agents in the therapy of ventricular arrhythmias in the post-CAST era].
    Candinas R; Bauersfeld U
    Schweiz Med Wochenschr; 1994 Sep; 124(35):1545-9. PubMed ID: 7939521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Role of determination of QT dispersal intervals in anti-arrhythmia therapy].
    Konecná P; Dvorák R; Semrád B
    Vnitr Lek; 1999 Aug; 45(8):453-6. PubMed ID: 11045143
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Beta-blocking agents vs. antiarrhythmic interventions in heart failure complicated by arrhythmias.
    Meinertz T; Hofmann T; Zehender M; Drexler H; Hohnloser S; Just H
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S151-7. PubMed ID: 11527120
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacologic therapy in patients with ventricular tachyarrhythmias.
    Wyse DG
    Cardiol Clin; 1993 Feb; 11(1):65-83. PubMed ID: 8435825
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Empiric antiarrhythmic drug therapy in patients with arrhythmogenic right ventricular cardiomyopathy/dysplasia: pragmatism or anachronism?
    Mitchell LB
    J Am Coll Cardiol; 2009 Aug; 54(7):616-7. PubMed ID: 19660691
    [No Abstract]   [Full Text] [Related]  

  • 11. Suppression by propranolol and amiodarone of an electrical storm refractory to metoprolol and amiodarone.
    Tsagalou EP; Kanakakis J; Rokas S; Anastasiou-Nana MI
    Int J Cardiol; 2005 Mar; 99(2):341-2. PubMed ID: 15749200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation and treatment strategies in patients at high risk of sudden death post myocardial infarction.
    Lewis WR
    Clin Cardiol; 1997 Nov; 20(11):910. PubMed ID: 9383581
    [No Abstract]   [Full Text] [Related]  

  • 13. [Drug treatment of chronic ventricular arrhythmia].
    Motté G; Slama M; Dinanian S; Sebag C
    Arch Mal Coeur Vaiss; 1992 Dec; 85 Spec No 4():85-9. PubMed ID: 1284883
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drug therapy of sustained ventricular tachyarrhythmias. Is there still a role?
    Mitchell LB
    Cardiol Clin; 2000 May; 18(2):357-73, viii-ix. PubMed ID: 10849878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Clinical significance of electrophysiologic drug testing in the longterm therapy of class I, III and IV antiarrhythmic drugs for recurrent ventricular tachyarrhythmia].
    Kasanuki H; Ohnishi S; Amamiya K; Umemura J; Shoda M; Hosoda S
    Jpn Circ J; 1992; 56 Suppl 5():1458-61. PubMed ID: 1291742
    [No Abstract]   [Full Text] [Related]  

  • 16. Antiarrhythmic action of beta-blockers: potential mechanisms.
    Dorian P
    J Cardiovasc Pharmacol Ther; 2005 Jun; 10 Suppl 1():S15-22. PubMed ID: 15965568
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of electrophysiologic testing with Holter monitoring to predict antiarrhythmic-drug efficacy for ventricular tachyarrhythmias. Electrophysiologic Study versus Electrocardiographic Monitoring Investigators.
    Mason JW
    N Engl J Med; 1993 Aug; 329(7):445-51. PubMed ID: 8332149
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mid-term clinical condition and prognosis in adrenergic ventricular tachycardia in children with apparently normal hearts].
    Drago F; Vignati G; Agostino DA; Mauri L; Calzolari A; Figini A; Ragonese P
    G Ital Cardiol; 1997 Apr; 27(4):349-56. PubMed ID: 9244739
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Therapeutic strategies in acute myocardial infarction: antiarrhythmic therapy].
    Le Heuzey JY; Copie X; Iliou MC; Guize L
    Arch Mal Coeur Vaiss; 1998 Apr; 91 Spec No 2():39-42. PubMed ID: 9749275
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interaction of bisoprolol and procainamide in human cardiac impulse generation and conduction.
    Verrostte JM; van Hemel NM; Kingma JH
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S193-5. PubMed ID: 11527128
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.